Skip to main content

Published locations for PROTECT: Pazopanib falls short as adjuvant therapy for high-risk RCC

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. PROTECT: Pazopanib falls short as adjuvant therapy for high-risk RCC

User login

  • Reset your password
  • /content/protect-pazopanib-falls-short-adjuvant-therapy-high-risk-rcc
  • /oncologypractice/article/140740/renal-cell-carcinoma/protect-pazopanib-falls-short-adjuvant-therapy
  • /hematology-oncology/article/140740/renal-cell-carcinoma/protect-pazopanib-falls-short-adjuvant